首页> 外文期刊>Leukemia Research Reports >A rare case of B cell lymphoblastic leukemia with inv(7)(p15q34) with review of literature.
【24h】

A rare case of B cell lymphoblastic leukemia with inv(7)(p15q34) with review of literature.

机译:罕见的B细胞淋巴细胞白血病,具有inv(7)(p15q34),文献综述。

获取原文
       

摘要

The inv(7)(p15q34) chromosomal abnormality which juxtaposes part of the HOXA gene cluster on 7p15 to the TCRβ locus on 7q34, has been described in a subset of cases of T-cell lymphoblastic leukemia, but its presence in cases of B-cell lymphoblastic leukemia is virtually unknown. Herewith, we report a case of a B-cell lymphoblastic leukemia with inv(7)(p15q34). The patient received standard induction chemotherapy, which failed to produce remission. After treatment with blinatumomab, a bispecific T-cell engager, the follow-up bone marrow biopsy showed no evidence of persistent/ relapsed B-cell lymphoblastic leukemia. The unique cytogenetics of this case may have contributed to its resistance of standard induction chemotherapy.
机译:在7Q15上并列在7P15至TCRβ基因座上并列在7Q34的情况下对T-Cell淋巴细胞白血病病例的组成,但在B-的情况下,已经描述了在7Q34的TCRβ基因座中的一部分Hoxa基因簇的染色体异常。 细胞淋巴细胞白血病几乎未知。 在这里,我们报告了具有INV(7)(P15Q34)的B细胞淋巴细胞白血病的情况。 患者接受了标准的诱导化疗,未能产生缓解。 在用Blinatumomab进行治疗后,一种双特异性T细胞录音机,随后的骨髓活检显示没有持久/复发的B细胞淋巴细胞白血病的证据。 这种情况的独特细胞源可能导致其标准诱导化疗的抵抗力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号